Tonix Pharmaceuticals Hld

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oral Presentation Describes Activity of Wnt/β-Catenin Signaling Pathway Inhibitors Against SARS-CoV-2 in Cell Culture and in an Animal Model Oral Presentation Describes Activity of Wnt/β-Catenin Signaling Pathway Inhibitors Against SARS-CoV-2 in Cell Culture and in an Animal Model

Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology

Poster Presentation Includes Preclinical Data from Tonix's Program to Develop a Vaccine for Monkeypox and Smallpox Poster Presentation Includes Preclinical Data from Tonix's Program to Develop a Vaccine for Monkeypox and Smallpox

Tonix Pharmaceuticals Announces Presentation on TNX-801 Vaccine Protection Against Monkeypox at the 4th Symposium of the Canadian Society for Virology

CHATHAM, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present at the 2022 BIO International Convention being held June 13-16, 2022 in San Diego, CA. The presentation will take place on Monday, June 13, 2022 at 3:45 p.m. PT in Theater 4 of the San Diego Convention Center.

Tonix Pharmaceuticals Announces Presentation at the 2022 BIO International Convention

Tonix Pharmaceuticals Corp (NASDAQ: TNXP) was up 25% after announcing that the US Patent and Trademark Office gave it a US Patent No. 11,342,896 on May 31, 2022.

Tonix Pharmaceuticals jumps 25%, and here is why

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 6.03% to $2.96 during Thursday's pre-market session. The company announced Thursday that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq.

What's Going On With Tonix Pharmaceuticals Shares Today?

Energy Focus

vTv Therapeutics

Check these penny stocks out for your watchlist right now The post Hot Penny Stocks to Watch That Are Climbing Right Now  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks to Watch That Are Climbing Right Now

TNXP stock is rallying because Tonix received a patent for its potential monkeypox vaccine and broader Recombinant Pox Virus platform. The post Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today?

Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Wednesday after the company announced that the United States Patent and Trademark Office issued a patent to Tonix titled, "Synthetic Chimeric Poxviruses." The patent includes claims covering.

Why Tonix Pharmaceuticals Stock Is Soaring

Shares of Tonix Pharmaceuticals Holding Corp. TNXP, +8.93% gained 43.8% in premarket trading on Wednesday after the company said the U.S. Patent and Trademark Office issued a patent to the company's poxvirus vaccine and its recombinant poxvirus platform. The horsepox-based live virus vaccine is being developed against monkeypox and smallpox.

Tonix's stock jumps 43% on patent for experimental pox vaccines

CHATHAM, N.J., May 31, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that its Board of Directors has approved a share repurchase program pursuant to which the Company may repurchase up to $12.5 million in value of its outstanding common stock, par value, $0.001 per share, from time to time on the open market and in privately negotiated transactions subject to market conditions, share price and other factors (the “Share Repurchase Program”). The Company intends to fund the Share Repurchase Program with available cash.

Tonix Pharmaceuticals Announces Share Repurchase Program

Blue Apron

Eos Energy Enterprises

Meta Materials

Vroom

Short squeeze stocks to watch this week. The post Best Penny Stocks?

Best Penny Stocks? 5 Short Squeeze Stocks To Watch This Week

Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital

Tonix Pharmaceuticals Announces Two Oral Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) on Prevention of Rejection in Kidney and Heart Allograft Transplantation at the 2022 American Transplant Congress

Applied Blockchain Inc

Beyond Meat

Fiverr

NuScale Power Corp

Block

Zscaler

While the market selloff has been a rough time for investors, it also gives them an opportunity to acquire growth stocks on the cheap. The post 7 Growth Stocks That Are Screaming Buys on Sale appeared first on InvestorPlace.

7 Growth Stocks That Are Screaming Buys on Sale

Chimerix

Emergent BioSolutions

Geovax Labs

Inovio Pharmaceuticals

SIGA Technologies

Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.

7 Monkeypox Stocks to Watch Right Now

Digital Brands Group Inc

iBio

Here's what you need to know about trading penny stocks on May 23rd The post What to Know About Buying Penny Stocks on May 23rd  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What to Know About Buying Penny Stocks on May 23rd

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. What's going on?

6 Stocks To Watch Amid Monkeypox Outbreak

Aethlon Medical

Monkeypox stocks to watch today. The post Penny Stocks To Buy Now?

Penny Stocks To Buy Now? Hot Monkeypox Stocks To Watch Today

Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox.

Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments

A spot of potentially good news can't stop the investor exodus from the biotech stock.

Why Tonix Pharmaceuticals Continued to Plummet Today

Tonix Exercises Option to License Antiviral Technology Platform Tonix Exercises Option to License Antiviral Technology Platform

Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop Antiviral Drugs Against SARS-CoV-2

The sell-off that began on Monday continues.

Why Tonix Pharmaceuticals Stock Is Crashing Again Today

A 1-for-32 reverse stock split of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has gone into effect. These are the details.

Tonix Pharmaceuticals (TNXP) Stock: 1-For-32 Reverse Split Goes Into Effect

You'd plummet to the ground too if you declared a major reverse stock split.

Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

Vinco Ventures

Markforged Holding Corp

Here's what you need to know about trading penny stocks on May 13th, 2022 The post What to Know About Buying Penny Stocks on May 13th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What to Know About Buying Penny Stocks on May 13th

Now is not a great time for pre-revenue biotechs to be reporting earnings.

Why Tonix Pharmaceuticals Got Crushed Today

News for Tonix Pharmaceuticals Hld Stock (TNXP)